X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-16 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.28 | -100,000 | 12,546,116 | -1% | -$928,005 | ||||||
2024-04-09 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.28 | -100,000 | 12,646,116 | -1% | -$927,735 | ||||||
M | 2024-03-22 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.12 | -97,610 | 12,746,116 | -1% | -$890,322 | |||||
M | 2024-03-19 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.03 | -2,390 | 12,843,726 | 0% | -$21,572 | |||||
M | 2024-03-13 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.14 | -100,000 | 12,846,116 | -1% | -$913,681 | |||||
2024-02-29 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.02 | -3,782 | 12,946,116 | 0% | -$34,101 | ||||||
M | 2024-02-26 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.02 | -99,478 | 12,949,898 | -1% | -$897,368 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |